Ultimately, our findings confirm that EZMLD induces apoptosis in ovarian cancer cells through the mechanism of METTL3 and METTL14 methyltransferases, which mediate KRT8 m6A methylation modification. This evidence concerns the gene METTL14 and ovarian carcinoma.